Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas

(2020) Jeremy S. Abramson et al.   BLOOD

Effective treatment of severe COVID-19 patients with tocilizumab

(2020) Xiaoling Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults

(2020) Surabhi B Vora et al.   Open Forum Infectious Diseases

Early and late hematologic toxicity following CD19 CAR-T cells

(2019) Shalev Fried et al.   BONE MARROW TRANSPLANTATION

Persistent Cytopenias after Chimeric Antigen Receptor T-Cell Immunotherapy for CD19+ Aggressive Lymphoma: A Single Institution Experience

(2019) George Nahas et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

(2019) Tania Jain et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells

(2019) Ana Cordeiro et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-Cell Malignancies

(2019) Feng Zhu et al.   BLOOD

Infections Associated with CAR T Therapy for Treatment of Hematological Malignancies

(2019) Tariq Iqtidar Sadiq Syed et al.   BLOOD

Infectious Complications Associated with CAR T-Cell Therapy

(2019) Lekha Mikkilineni et al.   BLOOD

Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients

(2019) Ying Wang et al.   BLOOD

A Multicenter Retrospective Analysis of Clinical Outcomes, Toxicities, and Patterns of Use in Institutions Utilizing Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas

(2019) Peter A. Riedell et al.   BLOOD

Invasive Mold Infections After Chimeric Antigen Receptor–Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis

(2019) Ghady Haidar et al.   CLINICAL INFECTIOUS DISEASES

Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

(2019) Ibrahim Yakoub-Agha et al.   HAEMATOLOGICA

Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

(2019) Hui Luo et al.   Journal for ImmunoTherapy of Cancer

Choosing Wisely BMT : American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation

(2018) Sita Bhella et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells

(2018) Jae H Park et al.   CLINICAL INFECTIOUS DISEASES

ASBMT Pharmacy Special Interest Group Survey on CAR T Cell Therapy Administrative, Logistical and Toxicity Management Practices in the United States

(2018) Zahra Mahmoudjafari et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

(2018) Frederick L Locke et al.   LANCET ONCOLOGY

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

(2018) Stephen J. Schuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

(2017) Sattva S. Neelapu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

(2016) Jo-Anne H. Young et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

(2016) V. G. Bhoj et al.   BLOOD